Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23303408 | 0.92 | ZDHHC20 (0.35) | ZDHHC20ZDHHC2 | |
| SCHEMBL24565593 | 0.90 | USP2 (0.32) | ZDHHC20ZDHHC2 | |
| SCHEMBL4372158 | 0.85 | — | — | |
| SCHEMBL4316811 | 0.84 | ZDHHC20 (0.41) | ZDHHC20ZDHHC2 | |
| SCHEMBL2046249 | 0.83 | ZDHHC20 (0.32) | ZDHHC20ZDHHC2 | |
| SCHEMBL9398065 | 0.83 | — | — | |
| SCHEMBL21611761 | 0.81 | CASP1 (0.33) | — | |
| SCHEMBL9396079 | 0.81 | — | — | |
| SCHEMBL907327 | 0.80 | ZDHHC20 (0.41) | ZDHHC20ZDHHC2 | |
| SCHEMBL14341773 | 0.79 | ZDHHC20 (0.38) | ZDHHC20ZDHHC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250360491-A1 | STATIONARY PHASE FOR CHROMATOGRAPHY | DAICEL CORPORATION (JP) | 2025-11-27 | — | — | US | disclosed |
| US-12403452-B2 | Stationary phase for chromatography | DAICEL CORPORATION (JP) | 2025-09-02 | — | — | US | disclosed |
| CN-119425650-A | Stationary phase for chromatography | 株式会社大赛璐 | 2025-02-14 | — | — | CN | disclosed |
| US-20240382933-A1 | METHOD FOR PRODUCING STATIONARY PHASE FOR COLUMN CHROMATOGRAPHY | DAICEL CORPORATION (JP) | 2024-11-21 | — | — | US | disclosed |
| EP-4410420-A1 | METHOD FOR PRODUCING STATIONARY PHASE FOR COLUMN CHROMATOGRAPHY | Daicel Corporation (JP) | 2024-08-07 | — | — | EP | disclosed |
| CN-117980066-A | Method for producing stationary phase for column chromatography | 株式会社大赛璐 | 2024-05-03 | — | — | CN | disclosed |
| EP-4063849-B1 | STATIONARY PHASE FOR SUPERCRITICAL FLUID CHROMATOGRAPHY | DAICEL CORP (JP) | 2024-01-31 | — | — | EP | disclosed |
| CN-112638519-B | stationary phase for chromatography | 株式会社大赛璐 | 2023-11-10 | — | — | CN | disclosed |
| WO-2023054507-A1 | METHOD FOR PRODUCING STATIONARY PHASE FOR COLUMN CHROMATOGRAPHY | 株式会社ダイセル | 2023-04-06 | — | — | WO | disclosed |
| EP-4063849-A1 | STATIONARY PHASE FOR SUPERCRITICAL FLUID CHROMATOGRAPHY | Daicel Corporation (JP) | 2022-09-28 | — | — | EP | disclosed |
| EP-1716836-A1 | Surface-modified fillers | Ivoclar Vivadent AG (LI) | 2006-11-02 | — | — | EP | disclosed |
| US-20040147647-A1 | Polyorganosiloxane micro-emulsion composition and raw material for cosmetics | DOW CORNING TORAY SILICONE CO., LTD. (JP) | 2004-07-29 | — | — | US | disclosed |
| US-20040138373-A1 | Polyorganosiloxane emulsion composition and a cosmetic material made therefrom | DOW TORAY CO., LTD. (JP) | 2004-07-15 | — | — | US | disclosed |
| CN-1505663-A | Polyorganosiloxane emulsion composition and a cosmetic material made therefrom | ������������ʽ���� | 2004-06-16 | — | — | CN | disclosed |
| US-20040091438-A1 | Polyorganosiloxane emulsions,process for producing the same and material for cosmetic preparation | DOW CORNING TORAY SILICONE CO. LTD. (JP) | 2004-05-13 | — | — | US | disclosed |
| EP-1406575-A2 | POLYORGANOSILOXANE MICRO-EMULSION COMPOSITION AND RAW MATERIAL FOR COSMETICS | Dow Corning Toray Silicone Co.,Ltd. Patent Department (JP) | 2004-04-14 | — | — | EP | disclosed |
| EP-1394215-A1 | POLYORGANOSILOXANE EMULSION, PROCESS FOR PRODUCING THE SAME, AND MATERIAL FOR COSMETIC PREPARATION | Dow Corning Toray Silicone Co., Ltd. (JP) | 2004-03-03 | — | — | EP | disclosed |
| EP-1381651-A1 | POLYORGANOSILOXANE EMULSION COMPOSITION AND A COSMETIC MATERIAL MADE THEREFROM | Dow Corning Toray Silicone Co.,Ltd. Patent Department (JP) | 2004-01-21 | — | — | EP | disclosed |
| WO-2002094213-A2 | POLYORGANOSILOXANE MICRO-EMULSION COMPOSITION AND RAW MATERIAL FOR COSMETICS | DOW CORNING TORAY SILICONE CO.,LTD. (JP) | 2002-11-28 | — | — | WO | disclosed |
| WO-2002088253-A1 | POLYORGANOSILOXANE EMULSION COMPOSITION AND A COSMETIC MATERIAL MADE THEREFROM | DOW CORNING TORAY SILICONE CO., LTD. (JP) | 2002-11-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040091438-A1 | Polyorganosiloxane emulsions,process for producing the same and material for cosmetic preparation | CUTA, UNG, PCNA | ZDHHC20 1137/4885ZDHHC2 1435/4885 |
| US-20040147647-A1 | Polyorganosiloxane micro-emulsion composition and raw material for cosmetics | UNG, PHOSPHO1, TPMT | ZDHHC20 1574/4885ZDHHC2 2148/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.